Exon-level expression analyses identify MYCN and NTRK1 as major determinants of alternative exon usage and robustly predict primary neuroblastoma outcome

by Schramm, A, Schowe, B, Fielitz, K, Heilmann, M, Martin, M, Marschall, T, Köster, J, Vandesompele, J, Vermeulen, J, de Preter, K, Koster, J, Versteeg, R, Noguera, R, Speleman, F, Rahmann, S, Eggert, A, Morik, K, Schulte, J H
Published 2012

A Cre-conditional MYCN-driven neuroblastoma mouse model as an improved tool for preclinical studies

by Althoff, K, Beckers, A, Bell, E, Nortmeyer, M, Thor, T, Sprüssel, A, Lindner, S, De Preter, K, Florin, A, Heukamp, L C, Klein-Hitpass, L, Astrahantseff, K, Kumps, C, Speleman, F, Eggert, A, Westermann, F, Schramm, A, Schulte, J H
Published 2015